How we got ahead in HIV control

July 25, 2014 by William Bowtell
From the late 1990s, the world galvanised in support of dramatic increases in funding for the distribution of HIV treatments to all who needed them. Credit: Shuttershock

When AIDS first emerged in the early 1980s, HIV infection was a death sentence. But a global effort has ensured this is no longer the case for a growing number of people.

The good news today is that the annual number of new global infections continues to fall – from the high point of some 3.4 million in 2001 to 2.3 million in 2012. And, as fewer people contract HIV, and more of those who do are given life-saving treatments, fewer progress to AIDS.

In 2005, some 2.3 million people died from AIDS, but this number had declined to 1.6 million in 2012. These figures indicate how far we have come in the long journey from AIDS to HIV.

Early efforts and innovation

Countries such as Australia that moved decisively to introduce effective HIV prevention policies in the mid-1980s generally saw a rapid falling away in numbers of new HIV infections.

But in most of the world, for a range of social, political and religious reasons, effective prevention measures were either not introduced or not implemented on a large enough scale to make a difference.

And it soon became clear that if the developing world were to survive the epidemic, new treatments would have to be provided at a scale and with a level of certainty that was unprecedented in the annals of global public health.

What was missing was the funding required to translate the potential of widespread access to treatments into tangible reality on the ground.

From the late 1990s, the world galvanised in support of dramatic increases in funding for the distribution of HIV treatments to all who required them.

Former US president Bill Clinton successfully pressed major pharmaceutical companies to greatly reduce the unit costs of new HIV treatments in the developing world. And thanks to the leadership of president George W Bush, the United States Congress appropriated $US50 billion for the President's Emergency Plan for AIDS Relief (PEPFAR).

In 2002, an innovative new financial mechanism, the Global Fund to Fight AIDS, Tuberculosis and Malaria was created to raise and channel new funding to countries wishing to increase access to HIV treatments. It has raised over $US30 billion to fight against the three diseases, and about half of this has funded access to HIV treatments in some 150 countries.

At the 2013 Global Fund replenishment conference in Washington DC, convened by President Barack Obama, governments, philanthropic, faith-based and private sector donors pledged over $US12 billion for the period 2014-16, a 30% increase over a similar 2010 effort.

Over nine million people worldwide now have access to life-saving HIV treatments, thanks to these two initiatives.

Changing direction

Taken together, this vast mobilisation of all kinds of human and material resources has utterly transformed the trajectory of the global HIV epidemic.

If they are on treatments, people who would once have died from AIDS are now living well with HIV; the number of children being born with HIV is falling dramatically; and above all, many millions of people who once would have surely acquired HIV, have not.

The world is now more than halfway along the path from AIDS to HIV, but none of these great achievements would have been possible without sustained funding commitments, stretching out over years and decades.

And in 2014, there is still much more to do.

Even though annual HIV funding from developed to developing countries is running at about $US18 billion, this is still about $US5 billion a year short of what's required to sustain the gains of the last decade. And there are many millions of people who are still without access to HIV treatments.

To consolidate our gains, and to drive new HIV infection rates down still further, billions of new dollars will be needed. But the required resources are not just going to come from the same old donors in the same old ways; we must develop innovative and imaginative new methods of securing critical funding.

The international response to HIV has always been a hotbed of radical policy innovation and implementation – from the bold prevention initiatives undertaken in Australia to the creation of the Global Fund itself.

By following the right strategies, backed by adequate funding, the world is closer towards the end of HIV and AIDS than at any time in the last three decades. Now is not the time to relent.

Explore further: Prejudicial views "enormous barriers to HIV prevention

Related Stories

Prejudicial views "enormous barriers to HIV prevention

July 17, 2014
HIV/AIDS is "not yesterday's issue; it is not a problem that has gone away", HIV campaigner Lord Norman Fowler has told a UNSW audience, arguing that the epidemic needs to be raised higher on the global public health agenda.

HIV epidemic 'smaller' than UN estimates: report

July 22, 2014
Anti-AIDS drugs have helped save 19 million years of human life since 1996, said an analysis Tuesday which also slashed UN estimates for HIV deaths and disease by a quarter.

Too soon for rich countries to stop HIV funding in poor ones

July 4, 2014
The global HIV epidemic has been unprecedented, both in its extent and in the way it has changed the world's approach to health funding.

Obama offers up to $5 billion to tackle AIDS (Update)

December 2, 2013
US President Barack Obama on Monday pledged up to $5 billion to fight HIV/AIDS as long as the rest of the world collectively offers double that amount.

A cure for HIV is a 'major scientific priority,' says researcher

June 24, 2014
Huge advancements have taken place in HIV treatment and prevention over the past 10 years, but there is still no cure or vaccine.

Uganda's president urged to veto 'flawed' HIV law

May 14, 2014
Rights groups are urging Uganda's president to veto a new measure that they say hurts the fight against HIV and AIDS in the country.

Recommended for you

New injectable antiretroviral treatment proved to be as effective as standard oral therapy

August 3, 2017
Intramuscularly administered antiretroviral therapy (ART) may be as effective for HIV treatment as current oral therapies. This is the main conclusion of a Phase II clinical trial carried out by 50 research centers around ...

Research finds home-based kit would increase HIV testing

July 31, 2017
Research led by William Robinson, PhD, Associate Research Professor of Behavioral & Community Health Sciences at LSU Health New Orleans School of Public Health, has found that 86% of heterosexuals who are at high risk for ...

Scientists divulge latest in HIV prevention

July 25, 2017
A far cry from the 1990s "ABC" campaign promoting abstinence and monogamy as HIV protection, scientists reported on new approaches Tuesday allowing people to have all the safe sex they want.

Girl's HIV infection seems under control without AIDS drugs

July 24, 2017
A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines—more evidence that early treatment can occasionally cause a long remission that, ...

Meds by monthly injection might revolutionize HIV care (Update)

July 24, 2017
Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay.

Candidate AIDS vaccine passes early test

July 24, 2017
The three-decade-old quest for an AIDS vaccine received a shot of hope Monday when developers announced that a prototype triggered the immune system in an early phase of human trials.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.